Inhibition of human mast cell activation with the novel selective adenosine A2B receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)
- 6 November 2001
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 62 (9) , 1163-1173
- https://doi.org/10.1016/s0006-2952(01)00765-1
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Anilide Derivatives of an 8-Phenylxanthine Carboxylic Congener Are Highly Potent and Selective Antagonists at Human A2B Adenosine ReceptorsJournal of Medicinal Chemistry, 2000
- Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma.Journal of Clinical Investigation, 1995
- 5'-adenosine monophosphate is the neutrophil-derived paracrine factor that elicits chloride secretion from T84 intestinal epithelial cell monolayers.Journal of Clinical Investigation, 1993
- Structure-activity relationships of 8-cycloalkyl-1,3-dipropylxanthines as antagonists of adenosine receptorsJournal of Medicinal Chemistry, 1990
- Effects of enprofylline and theophylline may show the role of adenosineLife Sciences, 1986
- Adenosine and asthmaTrends in Pharmacological Sciences, 1986
- Adenosine-induced bronchoconstriction in asthma: Role of mast cell-mediator releaseJournal of Allergy and Clinical Immunology, 1985
- Selective inhibition of cyclic nucleotide phosphodiesterases by analogs of 1-methyl-3-isobutylxanthineBiochemistry, 1977
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- 352. The synthesis of some 6-thioxanthinesJournal of the Chemical Society, 1962